Skip to main content
SpringerLink
Log in

Low-dose fludarabine plus cyclophosphamide is effective in patients with proliferative lupus nephritis, but is associated with considerable adverse outcomes

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Illei GG, Yarboro CH, Kuroiwa T, Schlimgen R, Austin HA, Tisdale JF, Chitkara P, Fleisher T, Klippel JH, Balow JE, Boumpas DT.Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis. Rheumatology 46: 952-956, No. 6, Jun 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Low-dose fludarabine plus cyclophosphamide is effective in patients with proliferative lupus nephritis, but is associated with considerable adverse outcomes. React. Wkly. 1164, 4 (2007). https://doi.org/10.2165/00128415-200711640-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711640-00011

Keywords

Search

Navigation